Results 251 to 260 of about 113,588 (316)
Editorial: Mechanisms of metastasis from circulating and disseminated tumor cells
Roberto Piñeiro, Roberto Piñeiro
doaj +1 more source
Liquid biopsy - a narrative review with an update on current US governmental clinical trials targeting immunotherapy. [PDF]
Shen F +4 more
europepmc +1 more source
The developed graphene‐assisted plasmonic nanocoral platform enables sensitive, label‐free surface‐enhanced Raman scattering analysis of salivary metabolites for head and neck cancer (HNC) detection. When combined with machine learning classification and nonnegative least squares‐based spectral deconvolution, this approach achieves 98% diagnostic ...
Hyo Jeong Seo +11 more
wiley +1 more source
Development and clinical applications of liquid biopsy assays in cancer screening. [PDF]
Han Y, Zhang P, Gong Y, Song L.
europepmc +1 more source
In patients with NELM, those with < 8 liver metastases and G1/2 tumors are the favorable candidates for liver resection. The important point of this study is that the patients who do not meet the above criteria should be considered for multidisciplinary treatment because of their extremely shorter recurrence‐free period.
Daisuke Asano +9 more
wiley +1 more source
Validation of a liquid biopsy assay with increased sensitivity for clinical comprehensive genomic profiling. [PDF]
Bower XS +19 more
europepmc +1 more source
ABSTRACT Aim The prognostic immune nutritional index (PINI) is increasingly recognized for its potential clinical utility. However, multifaceted evaluations of its ability to predict oncological outcomes in colorectal cancer (CRC) and its association with postoperative infectious complications remain limited.
Shinji Yamashita +9 more
wiley +1 more source
Shining the Path of Precision Diagnostic: Advancements in Photonic Sensors for Liquid Biopsy. [PDF]
Colapietro P +4 more
europepmc +1 more source
We systematically reviewed conversion therapy for esophageal squamous cell carcinoma and propose a response‐based treatment strategy for cT4b and M1 disease. For cT4b, we emphasize definitive chemoradiotherapy with timed re‐evaluation and selective salvage or chemoselection to surgery; for M1, conversion is reserved for limited‐burden responders with ...
Eisuke Booka, Hiroya Takeuchi
wiley +1 more source

